These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28697997)

  • 41. The Relationship between Insulin Resistance and Thyroid Volume in Georgia.
    Lomtadze N; Giorgadze E; Janjgava S; Kacharava T; Taboridze I
    Endocr Metab Immune Disord Drug Targets; 2023; 23(10):1318-1325. PubMed ID: 36825717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
    Hegde V; Dhurandhar NV; Reddy PH
    J Alzheimers Dis; 2019; 72(s1):S71-S79. PubMed ID: 31744006
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear Magnetic Resonance-Measured Ionized Magnesium Is Inversely Associated with Type 2 Diabetes in the Insulin Resistance Atherosclerosis Study.
    Garcia E; Shalaurova I; Matyus SP; Schutten JC; Bakker SJL; Dullaart RPF; Connelly MA
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents.
    Lin CW; Warram JH; Veng-Pedersen P
    J Pharmacokinet Pharmacodyn; 2011 Oct; 38(5):563-79. PubMed ID: 21833670
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Association between type 2 diabetes and physical activity in individuals with family history of diabetes].
    Petermann F; Díaz-Martínez X; Garrido-Méndez Á; Leiva AM; Martínez MA; Salas C; Poblete-Valderrama F; Celis-Morales C
    Gac Sanit; 2018; 32(3):230-235. PubMed ID: 29203323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998.
    Carnethon MR; Fortmann SP; Palaniappan L; Duncan BB; Schmidt MI; Chambless LE
    Am J Epidemiol; 2003 Dec; 158(11):1058-67. PubMed ID: 14630601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The association of hyperinsulinemia with cardiovascular risk and cancer poses new challenges in the treatment of the insulin resistance type 2 diabetes patient].
    Nubiola A; Ferrer M; Remolins I
    Hipertens Riesgo Vasc; 2015; 32(1):21-6. PubMed ID: 26179854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperinsulinemia: beneficial or harmful or both on glucose homeostasis.
    Xing J; Chen C
    Am J Physiol Endocrinol Metab; 2022 Jul; 323(1):E2-E7. PubMed ID: 35635329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey.
    Zhou L; Luo Y; Wang Y; Cheng Y; Zhang R; Zhang S; Gong S; Han X; Ji L
    Front Clin Diabetes Healthc; 2023; 4():1172208. PubMed ID: 37324170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk Assessment and Determination of Factors That Cause the Development of Hyperinsulinemia in School-Age Adolescents.
    Lukic I; Savic N; Simic M; Rankovic N; Rankovic D; Lazic L
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056318
    [No Abstract]   [Full Text] [Related]  

  • 51. Higher scores of dietary and lifestyle inflammatory indices are associated with increased risk of insulin-related disorders in Iranian adults.
    Farhadnejad H; Teymoori F; Mokhtari E; Mirmiran P; Azizi F
    Eur J Clin Nutr; 2022 Nov; 76(11):1566-1575. PubMed ID: 35444270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased cell senescence in human metabolic disorders.
    Spinelli R; Baboota RK; Gogg S; Beguinot F; Blüher M; Nerstedt A; Smith U
    J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. iPSCs derived from insulin resistant offspring of type 2 diabetic patients show increased oxidative stress and lactate secretion.
    Memon B; Elsayed AK; Bettahi I; Suleiman N; Younis I; Wehedy E; Abou-Samra AB; Abdelalim EM
    Stem Cell Res Ther; 2022 Aug; 13(1):428. PubMed ID: 35987697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Impact of Insulin Resistance on Cardiovascular Control During Exercise in Diabetes.
    Mizuno M; Hotta N; Ishizawa R; Kim HK; Iwamoto G; Vongpatanasin W; Mitchell JH; Smith SA
    Exerc Sport Sci Rev; 2021 Jul; 49(3):157-167. PubMed ID: 33965976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Parental Transmission Plays the Major Role in High Aggregation of Type 2 Diabetes in Iranian Families: Tehran Lipid and Glucose Study.
    Akbarzadeh M; Riahi P; Ramezankhani A; Dehkordi SR; Roudbar MA; Zarkesh M; Guity K; Khalili D; Zahedi AS; Azizi F; Daneshpour MS
    Can J Diabetes; 2022 Feb; 46(1):60-68. PubMed ID: 34419346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic influences on glucose neurotoxicity, aging, and diabetes: a possible role for glucose hysteresis.
    Mobbs CV
    Genetica; 1993; 91(1-3):239-53. PubMed ID: 8125273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycemic index, hyperinsulinemia, and breast cancer risk.
    Key TJ
    Ann Oncol; 2001 Nov; 12(11):1507-9. PubMed ID: 11822747
    [No Abstract]   [Full Text] [Related]  

  • 58. Heterogeneous effects on type 2 diabetes and cardiovascular outcomes of genetic variants and traits associated with fasting insulin.
    Manning A; Sevilla-González M; Smith K; Wang N; Jensen A; Litkowski E; Kim H; DiCorpo D; Westerman K; Cui J; Liu CT; Yu C; McNeil J; Lacaze P; Chang KM; Tsao P; Phillips L; Goodarzi M; Sladek R; Rotter J; Dupuis J; Florez J; Merino J; Meigs J; Zhou J; Raghavan S; Udler M
    Res Sq; 2023 Sep; ():. PubMed ID: 37790568
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of gene expression profile following consumption of high-dairy products in subjects with hyperinsulinemia.
    Khorraminezhad L; Rudkowska I
    Nutr Metab Cardiovasc Dis; 2023 Jan; 33(1):219-226. PubMed ID: 36411217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Added Sugars Drive Insulin Resistance, Hyperinsulinemia, Hypertension, Type 2 Diabetes and Coronary Heart Disease.
    DiNicolantonio JJ; O'Keefe JH
    Mo Med; 2022; 119(6):519-523. PubMed ID: 36588634
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.